[1]
Natalia Bylak, “GLP-1 RECEPTOR AGONISTS AS EMERGING THERAPEUTICS FOR SUBSTANCE USE DISORDERS: A REVIEW OF MECHANISMS, EFFICACY, AND PUBLIC HEALTH IMPLICATIONS”, IJITSS, vol. 2, no. 1(49), Mar. 2026, doi: 10.31435/ijitss.1(49).2026.5071.